Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice

Abstract

To control G protein signaling in vivo, we have modified G protein–coupled receptors to respond exclusively to synthetic small molecule agonists and not to their natural agonist(s). These engineered receptors are designated RASSLs (receptor activated solely by a synthetic ligand). A prototype RASSL (Ro1) based on the Gi–coupled κ opioid receptor was expressed in transgenic mice under the control of the tetracycline transactivator (tet) system. Activation of Ro1 expressed in the heart decreased heart rate by up to 80%, an expected effect of increased Gi signaling. Maximal heart rate changes occurred in less than 1 min, demonstrating the speed of this inducible signaling system. This Ro1–mediated slowing of heart rate was also subject to desensitization, which lasted more than 24 h. Both the initial effect on heart rate and the desensitization occurred, even though Ro1 is derived from a human opioid receptor not normally involved in heart rate control. In addition, the tet system was used to induce Ro1 expression in hepatocytes and salivary gland, where Gi signaling is known to control physiologic events such as proliferation and secretion. These studies demonstrate that a RASSL can be inducibly expressed in several mouse tissues and used in vivo to activate G protein signaling in a controllable fashion.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Conditional and tissue–specific expression of Ro1 in heart, liver, and salivary gland.
Figure 2: Timing of Ro1 expression in the heart.
Figure 3: Inducible β–gal activity in the atria and ventricles of αMHC–tTA/tetO–Ro1/tetO–lacZ mice.
Figure 4: Spiradoline–mediated bradycardia in mice with cardiac Ro1 expression.
Figure 5: (A) Spiradoline–mediated bradycardia occurs immediately.
Figure 6: Average decrease in heart rate for five mice (n = 4 at 4 h) treated with spiradoline at 4, 28, and 168 h after initial injection (1 × 10–5 mol/kg).

Similar content being viewed by others

References

  1. Gossen, M. and Bujard, H. 1992. Tight control of gene expression in mammalian cells by tetracycline–responsive promoters. Proc. Natl. Acad. Sci. USA 89: 5547–5551.

    Article  CAS  Google Scholar 

  2. Spencer, D.M., Wandless, T.J., Schreiber, S.L., and Crabtree, G.R. 1993. Controlling signal transduction with synthetic ligands. Science 262:1019– 1024.

    Article  CAS  Google Scholar 

  3. Wang, Y., O'Malley, B.W., Jr., Tsai, S.Y., and O'Malley, B.W. 1994. A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 91: 8180–8184.

    Article  CAS  Google Scholar 

  4. No, D., Yao, T.–P., and Evans, R.M. 1996. Ecdysone–inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93:3346–3351.

    Article  CAS  Google Scholar 

  5. Coward, P., Wada, H.G., Falk, M.S., Chan, S.D.H., Meng, F., Akil, H., and Conklin, B.R. 1998. Controlling signaling with a specifically designed Gi–coupled receptor. Proc. Natl. Acad. Sci. USA 95:352– 357.

    Article  CAS  Google Scholar 

  6. Lefkowitz, R.J., Hoffman, B.B., and Taylor, P. 1990. Neurohumoral transmission: the autonomic and somatic motor nervous systems, pp. 84– 121 in Goodman and Gilman's the Pharmacological Basis of Therapeutics . Gilman, A.G., Rall, T.W., Nies, A.S., and Taylor, P. (eds.). Pergamon Press, New York, NY.

    Google Scholar 

  7. Holmer, S.R. and Homcy, C.J. 1991. G proteins in the heart: a redundant and diverse transmembrane signaling network. Circulation 84:1891–1902.

    Article  CAS  Google Scholar 

  8. Newton, G.E., Parker, A.B., Landzberg, J.S., Colucci, W.S., and Parker, J.D. 1996. Muscarinic receptor modulation of basal and b–adrenergic stimulated function of the failing human left ventricle. J. Clin. Invest. 98:2756–2763.

    Article  CAS  Google Scholar 

  9. Fu, L.–X., Liang, Q.–M., Waagstein, F., Hoebeke, J., Sylvén, C., Jansson, E. et al. 1992. Increase in functional activity rather than in amount of Gi–a in failing human heart with dilated cardiomyopathy. Cardiovasc. Res. 26:950– 955.

    Article  CAS  Google Scholar 

  10. Yu, Z., Redfern, C.S., and Fishman, G.I. 1996. Conditional transgene expression in the heart. Circ. Res. 79:691– 697.

    Article  CAS  Google Scholar 

  11. Kistner, A., Gossen, M., Zimmerman, F., Jerecic, J., Ullmer, C., Lübbert, H. et al. 1996. Doxycycline–mediated quantitative and tissue–specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93:10933 –10938.

    Article  CAS  Google Scholar 

  12. Ewald, D., Li, M., Efrat, S., Auer, G., Wall, R.J., Furth, P.A. et al. 1996. Time–sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273:1384– 1386.

    Article  CAS  Google Scholar 

  13. Appleyard, S.M., Patterson, T.A., Jin, W., and Chavkin, C. 1997 . Agonist–induced phosphorylation of the κ–opioid receptor. J. Neurochem. 69:2405– 2412.

    Article  CAS  Google Scholar 

  14. Sterne–Marr, R. and Benovic, J.L. 1995 . Regulation of G protein–coupled receptors by receptor kinases and arrestins. Vitam. Horm. 51:193– 234.

    Article  Google Scholar 

  15. Freedman, N.J. and Lefkowitz, R.J. 1996. Desensitization of G protein–coupled receptors. Recent Prog. Horm. Res. 51:319–353 .

    CAS  PubMed  Google Scholar 

  16. Schwenk, F., κühn, R., Angrand, P.–O., Rajewsky, K., and Stewart, A.F. 1998 . Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res. 26:1427– 1432.

    Article  CAS  Google Scholar 

  17. Ho, S.N., Biggar, S.R., Spencer, D.M., Schreiber, S.L., and Crabtree, G.R. 1996. Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature 382:822–826.

    Article  CAS  Google Scholar 

  18. Farrar, M.A., Alberola–Ila, J., and Perlmutter, R.M. 1996. Activation of the Raf–1 kinase cascade by coumermycin–induced dimerization. Nature 383:178–181.

    Article  CAS  Google Scholar 

  19. Spencer, D.M. 1996. Creating conditional mutations in mammals. Trends Genet. 12:181–187.

    Article  CAS  Google Scholar 

  20. Milano, C.A., Allen, L.F., Rockman, H.A., Dolber, P.C., McMinn, T.R., Chien, K.R. et al. 1994. Enhanced myocardial function in transgenic mice overexpressing the b2–adrenergic receptor. Science 264:582– 586.

    Article  CAS  Google Scholar 

  21. Böhm, M., Eschenhagen, T., Gierschik, P., Larisch, K., Lensche, H., Mende, U. et al. 1994. Radioimmunochemical quantification of Gia in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. J. Mol. Cell. Cardiol. 26:133–149.

    Article  Google Scholar 

  22. Schnabel, P. and Böhm, M. 1996. Heterotrimeric G proteins in heart disease. Cell. Signal. 8: 413–423.

    Article  CAS  Google Scholar 

  23. Spiegel, A.M., Shenker, A., and Weinstein, L.S. 1992. Receptor–effector coupling by G proteins: implications for normal and abnormal signal transduction. Endocr. Rev. 13:536–565 .

    Article  CAS  Google Scholar 

  24. Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A. et al. 1998. Disruption of the κ–opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ–agonist U–50,488H and attenuates morphine withdrawal. EMBO J. 17:886–897.

    Article  CAS  Google Scholar 

  25. http://gladstone.ucsf.edu/conklin.html.

  26. http://www.jax.org.

Download references

Acknowledgements

We thank Robert W. Mahley and Murielle M. Veniant for valuable discussions and advice; Lara Jensen and Dale Newland for histochemistry assistance; and Gary Howard, Stephen Ordway, and Jane Peredo for editorial assistance. G. Fishman is an established investigator of the American Heart Association. This work was supported by the J. David Gladstone Institutes and the National Institutes of Health Grants CA71779 (C.H.R.) and HL60664–01 (B.R.C.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bruce R. Conklin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Redfern, C., Coward, P., Degtyarev, M. et al. Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice. Nat Biotechnol 17, 165–169 (1999). https://doi.org/10.1038/6165

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/6165

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing